Autologous and Heterologous Neutralization Analyses of Primary Feline Immunodeficiency Virus Isolates

AUTOR(ES)

del Mauro, Daniela

FONTE

American Society for Microbiology

RESUMO

Feline immunodeficiency virus (FIV) provides a model system with which the significance of neutralizing antibody (NA) in immunosuppressive lentivirus infections may be studied. To date, no detailed analysis of the neutralization properties of primary FIV isolates has been reported. In this study, we have conducted the first comprehensive study of the sensitivity to autologous and heterologous neutralization in a lymphoid cell-based assay of 15 primary FIV isolates and, for comparison, of one tissue culture-adapted strain. Primary isolates in general proved highly NA resistant, although there was considerable individual variation. Variation was also observed in the capacity of immune sera to neutralize heterologous FIV isolates. The ability of sera to neutralize isolates or for isolates to be neutralized by sera did not correlate with epidemiological and genetic relatedness or with the quasispecies complexity of the isolates. From the study of specific-pathogen-free cats experimentally infected with viral isolates associated with NA of different breadths, it appears that the development of FIV vaccines cannot rely on the existence of viral strains inherently capable of inducing especially broad NA responses.

Documentos Relacionados

• Antibody Neutralization-Resistant Primary Isolates of Human Immunodeficiency Virus Type 1
• Detection of Antibody-Dependent Complement-Mediated Inactivation of both Autologous and Heterologous Virus in Primary Human Immunodeficiency Virus Type 1 Infection†
• Antibody Binding and Neutralization of Primary and T-Cell Line-Adapted Isolates of Human Immunodeficiency Virus Type 1
• Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus.
• Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.